Neogen Corporation to Participate in 2026 UBS Global Healthcare Conference
Neogen Corporation announced its participation in the upcoming 2026 UBS Global Healthcare Conference scheduled for November 10, 2026.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Neogen Corporation announced its participation in the upcoming 2026 UBS Global Healthcare Conference scheduled for November 10, 2026.
Filed: 2026-10-26 AccNo: 0001193125-26-431208 Size: 160 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Neogen (NEOG) stock rises after outlining ambitious FY31 targets at Investor Day, including 30% EBITDA margins & R&D expansion.
Neogen beats Q1 2027 estimates with $222.8 million in revenue and 8 cents adjusted EPS, raising full-year fiscal 2027 sales and EBITDA guidance.
Penguin Solutions jumped 7.7% after beating Q4 revenue/EPS estimates and issuing above-consensus FY27 EPS guidance.